Skip to main content

Table 1 Sociodemographic and clinical characteristics of the patients included in the study

From: Development of a new multimedia instrument to measure cancer-specific quality of life in Portuguese-speaking patients with varying literacy skills

Characteristic Phase I Phase II Phase III Phase IV Phase VI
(n = 20) (n = 60) (n = 149) (n = 323) (n = 54)
n % n % n % n % n %
Gender
 Male 8 40.0 27 45.0 49 32.9 151 46.7 36 60.0
 Female 12 60.0 33 55.0 100 67.1 172 53.3 24 40.0
Age (years)
 <40 1 5.0 12 20.0 39 26.2 45 13.9 10 16.7
 40–65 16 80.0 35 58.3 91 61.1 197 61.0 41 68.3
 ≥65 3 15.0 13 21.7 19 12.8 81 25.1 9 15.0
Educational level (years of formal schooling)
 Illiterate 0 0 0 0 4 2.7 16 5.0 4 6.7
 <8 5 25.0 23 38.3 56 37.6 145 44.9 27 45.0
 8–11 6 30.0 16 26.7 26 17.4 84 26.0 24 44.0
 >11 9 45.0 21 35.0 63 42.3 78 24.1 5 8.3
Family income (expressed as multiples of the minimum wage)
 ≤1 3 15.0 14 25.0 29 19.7 52 17.9 23 38.3
 1–2 8 40.0 11 19.6 51 34.7 63 21.7 18 30.0
 2.1–3 4 20.0 12 21.4 26 17.7 49 16.9 10 16.7
 >3 5 25.0 19 33.9 41 27.9 126 43.4 7 12.0
 Missing 0   4   2   33   2  
Brazilian region of origin
 Southeast 14 70.0 42 70.0 106 71.1 257 79.6 43 71.7
 Southern 0 0 1 1.7 1 0.7 1 0.3 0 0.0
 Northern 1 5.0 4 6.7 7 4.7 22 6.8 7 11.7
 Midwest 5 25.0 13 21.7 34 22.8 40 12.4 8 13.3
 Northeast 0 0 0 0 1 0.7 3 0.9 2 3.3
Type of primary tumor
 Breast 5 25.0 12 20.0 53 35.6 73 22.6 5 8.3
 Colorectal 4 20.0 15 25.0 25 16.8 38 11.8 3 5.0
 Prostate 2 10.0 7 11.7 10 6.7 33 10.2 2 3.3
 Cervix 1 5.0 3 5.0 16 10.7 19 5.9 0 0
 Gastric 1 5.0 1 1.7 8 5.4 9 2.8 0 0
 Lung 0 0 4 6.7 3 2.0 22 6.8 0 0
 Head and Neck 0 0 4 6.7 2 1.3 33 10.2 40 66.7
 Esophageal 1 5.0 1 1.7 4 2.7 7 2.2 0 0
 Endometrial 0 0 0 0 2 1.3 1 0.3 0 0
 Others 6 30.0 13 21.7 26 17.4 88 27.2 10 16.7
Distant metastasis
 Yes 11 55.0 31 52.0 61 41 158 48.9 15 25.0
 No 9 45.0 29 48.0 88 59 165 51.1 45 75.0
Type of current treatment
 Follow-up (NED) 0 0 11 18.3 16 10.7 45 13.9 3 5.0
 Curative/Adj/Neoadj systemic therapy 4 20.0 18 30.0 72 48.3 120 37.2 45 75.0
 Palliative systemic therapy 10 50.0 21 35.0 56 37.6 132 40.9 10 16.7
 Palliative care only 6 30.0 10 16.7 5 3.5 26 8.0 2 3.3
Place of interview
 Ambulatory 9 45.0 56 93.0 117 78.5 288 89.2 59 98.3
 Hospital 11 55.0 4 7.0 32 21.5 35 10.8 1 1.7
ECOG performance status
 0–1 8 40.0 NA 109 73.2 220 68.8 54 90.0
 2–4 12 60.0 NA 39 26.2 100 31.3 6 10.0
 Missing        3    
  1. NED no evidence of disease, Adj Adjuvant, Neoadj Neoadjuvant, ECOG Eastern Cooperative Oncology Group